1. Home
  2. MOLN vs SUNS Comparison

MOLN vs SUNS Comparison

Compare MOLN & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • SUNS
  • Stock Information
  • Founded
  • MOLN 2004
  • SUNS 2023
  • Country
  • MOLN Switzerland
  • SUNS United States
  • Employees
  • MOLN N/A
  • SUNS N/A
  • Industry
  • MOLN
  • SUNS Real Estate Investment Trusts
  • Sector
  • MOLN
  • SUNS Real Estate
  • Exchange
  • MOLN Nasdaq
  • SUNS Nasdaq
  • Market Cap
  • MOLN 142.6M
  • SUNS 142.3M
  • IPO Year
  • MOLN 2021
  • SUNS N/A
  • Fundamental
  • Price
  • MOLN $3.67
  • SUNS $11.07
  • Analyst Decision
  • MOLN
  • SUNS Strong Buy
  • Analyst Count
  • MOLN 0
  • SUNS 3
  • Target Price
  • MOLN N/A
  • SUNS $13.58
  • AVG Volume (30 Days)
  • MOLN 1.1K
  • SUNS 68.1K
  • Earning Date
  • MOLN 09-05-2025
  • SUNS 08-07-2025
  • Dividend Yield
  • MOLN N/A
  • SUNS 11.41%
  • EPS Growth
  • MOLN N/A
  • SUNS N/A
  • EPS
  • MOLN N/A
  • SUNS 1.04
  • Revenue
  • MOLN $2,525,030.00
  • SUNS $16,359,932.00
  • Revenue This Year
  • MOLN N/A
  • SUNS $185.50
  • Revenue Next Year
  • MOLN $1,000.00
  • SUNS $64.44
  • P/E Ratio
  • MOLN N/A
  • SUNS $10.61
  • Revenue Growth
  • MOLN N/A
  • SUNS 1342.10
  • 52 Week Low
  • MOLN $3.36
  • SUNS $7.80
  • 52 Week High
  • MOLN $7.60
  • SUNS $15.74
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 52.01
  • SUNS 61.71
  • Support Level
  • MOLN $3.53
  • SUNS $10.25
  • Resistance Level
  • MOLN $3.59
  • SUNS $10.85
  • Average True Range (ATR)
  • MOLN 0.07
  • SUNS 0.35
  • MACD
  • MOLN 0.00
  • SUNS 0.09
  • Stochastic Oscillator
  • MOLN 43.75
  • SUNS 87.61

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: